Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Alphs

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Psychiatry|June 18, 1999
Clozapine: the commitment to patient safetyL D Alphs, R Anand
Modern Problems of Pharmacopsychiatry|January 1, 1983
Cholinergic treatments for tardive dyskinesiaL D Alphs, J M Davis
The Journal of Clinical Psychiatry|August 1, 1991
Comparison of withdrawal of typical and atypical antipsychotic drugs: a case studyL D Alphs, H S Lee
Schizophrenia Research|March 1, 1993
Training novice raters on the Negative Symptom Assessment ScaleB N Axelrod, L D Alphs
Psychopharmacology|January 1, 1989
Development of the Clozaril Patient Management SystemB Bastani, L D Alphs, H Y Meltzer
Psychopharmacology Bulletin|January 1, 1986
Cholecystokinin: a neuropeptide in the treatment of schizophreniaC A Tamminga, R L Littman, L D Alphs
Schizophrenia Bulletin|January 1, 1985
Treatment of negative symptomsW T Carpenter, D W Heinrichs, L D Alphs
Psychiatry Research|April 1, 1991
Isometric force control in schizophrenic patients with tardive dyskinesiaP B Vrtunski, L D Alphs, H Y Meltzer
Journal of Psychiatric Research|July 1, 1993
Validation of the 16-item Negative Symptom AssessmentB N Axelrod, R S Goldman, L D Alphs
Psychiatry Research|October 1, 1994
Motor mechanisms in schizophrenic patients with tardive dyskinesiaP B Vrtunski, L D Alphs, H Y Meltzer
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Psychiatry|June 18, 1999
Clozapine: the commitment to patient safetyL D Alphs, R Anand
Modern Problems of Pharmacopsychiatry|January 1, 1983
Cholinergic treatments for tardive dyskinesiaL D Alphs, J M Davis
The Journal of Clinical Psychiatry|August 1, 1991
Comparison of withdrawal of typical and atypical antipsychotic drugs: a case studyL D Alphs, H S Lee
Schizophrenia Research|March 1, 1993
Training novice raters on the Negative Symptom Assessment ScaleB N Axelrod, L D Alphs
Psychopharmacology|January 1, 1989
Development of the Clozaril Patient Management SystemB Bastani, L D Alphs, H Y Meltzer
Psychopharmacology Bulletin|January 1, 1986
Cholecystokinin: a neuropeptide in the treatment of schizophreniaC A Tamminga, R L Littman, L D Alphs
Schizophrenia Bulletin|January 1, 1985
Treatment of negative symptomsW T Carpenter, D W Heinrichs, L D Alphs
Psychiatry Research|April 1, 1991
Isometric force control in schizophrenic patients with tardive dyskinesiaP B Vrtunski, L D Alphs, H Y Meltzer
Journal of Psychiatric Research|July 1, 1993
Validation of the 16-item Negative Symptom AssessmentB N Axelrod, R S Goldman, L D Alphs
Psychiatry Research|October 1, 1994
Motor mechanisms in schizophrenic patients with tardive dyskinesiaP B Vrtunski, L D Alphs, H Y Meltzer
Pageof 3